- Research works
- 23 ▲ 6% vs 2013–17
- Citations
- 405 17.5 per fractional work
- Top-10% rate
- 28.9% record average 16.5%
- Open access
- 39% world 28%
Not ranked overall: Inventiva (France) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.0×. Every wedge is a field page.
Who are the top researchers at Inventiva (France)?
Ranked on the composite score, Jean‐Louis Junien lead among researchers whose main affiliation is Inventiva (France).
- 1 Jean‐Louis Junien France · #1,363,890 worldwide 26 citations · 21 works
Which keywords describe research at Inventiva (France)?
By fractional works in all years, weighted toward what it does more of than the world: Cancer, Regulation, Stem Cells, Hippo Pathway, YAP/TAZ, Metabolic Syndrome, DNA Methylation and Histone Modification.
- Peroxisome Proliferator-Activated Receptors
- Educational Leadership
- Diabetes
- Enzyme Replacement Therapy
- NAFLD
- Obesity
- Insulin Resistance
- DNA Methylation
- Inflammation
- Hippo Pathway
- Regulation
- Cancer
- Stem Cells
- YAP/TAZ
- Metabolic Syndrome
- Histone Modification
- Hepatic Steatosis
- Metabolism
- NASH
- Lysosomal Storage Disorders
- Transcriptional Regulation
- PPARs
- Quality Education
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 23 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 23 words, with their numbers
- Cancer3▲ 10×6 topics
- Regulation3▲ 20×2 topics
- Stem Cells3▲ 41×2 topics
- Hippo Pathway3▲ 944×1 topic
- YAP/TAZ3▲ 944×1 topic
- Inflammation2▲ 3.8×7 topics
- Metabolic Syndrome2▲ 10×5 topics
- DNA Methylation2▲ 70×1 topic
- Histone Modification2▲ 124×1 topic
- Insulin Resistance2▲ 15×3 topics
- Hepatic Steatosis2▲ 43×2 topics
- Obesity2▲ 8.3×4 topics
- Metabolism1▲ 9.0×4 topics
- NAFLD1▲ 53×1 topic
- NASH1▲ 53×1 topic
- Enzyme Replacement Therapy1▲ 207×1 topic
- Lysosomal Storage Disorders1▲ 286×1 topic
- Diabetes1▲ 9.4×2 topics
- Transcriptional Regulation1▲ 20×2 topics
- Educational Leadership1▲ 47×1 topic
- PPARs1▲ 141×1 topic
- Peroxisome Proliferator-Activated Receptors1▲ 141×1 topic
- Quality Education1▲ 168×1 topic
Which research topics does Inventiva (France) publish most on?
By volume in 2022–2025: Liver Disease Diagnosis and Treatment, Peroxisome Proliferator-Activated Receptors, Metabolism, Diabetes, and Cancer and Hormonal Regulation and Hypertension.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Liver Disease Diagnosis and Treatment Epidemiology 1 works
- 2 Peroxisome Proliferator-Activated Receptors Molecular Biology 0 works
- 3 Metabolism, Diabetes, and Cancer Molecular Biology 0 works
- 4 Hormonal Regulation and Hypertension Endocrinology, Diabetes and Metabolism 0 works
- 5 Pancreatitis Pathology and Treatment Surgery 0 works
- 6 Liver Disease and Transplantation Hepatology 0 works
- 7 Multiculturalism, Politics, Migration, Gender Political Science and International Relations 0 works
- 8 French Urban and Social Studies Sociology and Political Science 0 works
- 9 Diverse Cultural and Historical Studies Cultural Studies 0 works
- 10 Insect Utilization and Effects Insect Science 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Inventiva (France)'s research output changed?
Output in 2018–2022 was 6% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.